Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
ZymoGenetics Rival Emerges, Omeros IPO Casts Shadow, Microsoft’s HealthVault Seeks Users, & More Seattle Area Life Sciences News
|
Luke Timmerman |
10/29/09 |
Seattle
|
|
Zymo Gets $70M for Starting Trial
|
Luke Timmerman |
10/27/09 |
Seattle
|
|
ZymoGenetics’ Former Medical Boss Leads Rival Startup, ProFibrix, With Drug For Bleeding
|
Luke Timmerman |
10/26/09 |
Seattle
|
|
AVI Settles In, ZymoGenetics MS Drug Fails, Dendreon’s FDA Filing Set for Mid-November & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/01/09 |
Seattle
|
|
ZymoGenetics Partner Halts Multiple Sclerosis Trials After Drug Fails
|
Luke Timmerman |
09/28/09 |
Seattle
|
|
Biotech Pioneer Steve Gillis on Life as a VC, How Today’s Entrepreneurs Can Make It, and Seattle’s Future in Life Sciences (Part 1)
|
Luke Timmerman |
09/23/09 |
Seattle
|
|
The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009
|
Luke Timmerman |
09/22/09 |
Seattle
|
|
Novo Nordisk’s Historic Mistake is Seattle’s Future Gain, Says Novo CEO
|
Luke Timmerman |
09/18/09 |
Seattle
|
|
Omeros Moves Closer to IPO, Zymo Drug Fails Arthritis Trials, Uptake Medical Gets $3.4M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
09/17/09 |
Seattle
|
|
Zymo Drug Fails Arthritis Trials
|
Luke Timmerman |
09/10/09 |
Seattle
|
|
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/27/09 |
Seattle
|
|
Targeted Genetics’ Legacy: No Cures, But a Generation of Seattle Biotechies
|
Luke Timmerman |
08/25/09 |
Seattle
|
|
ZymoGenetics, Citing Two Patient Deaths, Builds Up Ammunition for Case Against Rival
|
Luke Timmerman |
08/20/09 |
Seattle
|
|
ZymoGenetics Plays Hardball, Asks FDA to Pull Competing Drug Off Market Because of Safety
|
Luke Timmerman |
08/20/09 |
Seattle
|
|
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/06/09 |
Seattle
|
|
Zymo Gets $6M in Q2 Recothrom Sales
|
Luke Timmerman |
08/03/09 |
Seattle
|
|
Dendreon May Not Survive Its Success: Q&A with Founder Chris Henney, Part 1
|
Luke Timmerman |
07/27/09 |
Seattle
|
|
ZymoGenetics Picks Up Mojo, Dendreon Looks Southeast, Cell Therapeutics Raises Dough & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/23/09 |
Seattle
|
|
ZymoGenetics Picks Up Some of Human Genome Sciences’ Mojo With Lupus Drug
|
Luke Timmerman |
07/21/09 |
Seattle
|
|
Johnson & Johnson, TB Alliance Form Partnership to Push New TB Drug Through Clinic
|
Luke Timmerman |
06/17/09 |
Seattle
|
|
Cell Therapeutics Shares Boom, Vulcan’s Breast Cancer Bombshell, Microsoft Buys Rosetta Assets, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
06/04/09 |
Seattle
|
|
ASCO Weekend Recap: OncoGenex, Seattle Genetics, Vulcan-Backed BiPar Show Off Cancer Drug Results
|
Luke Timmerman |
06/01/09 |
Seattle
|
|
ZymoGenetics Kidney Cancer Drug Shrinks, Stabilizes Tumors in Sickest Patients
|
Luke Timmerman |
05/31/09 |
Seattle
|
|
Vulcan’s Biotech Windfall, BiPar Sciences, Sparks “Fundamental” Cancer Advance
|
Luke Timmerman |
05/22/09 |
Seattle
|
|
NKT Therapeutics Aims For Severe Asthma, Targeting Natural Killer T Cells
|
Ryan McBride |
05/18/09 |
Boston
|
|
ASCO Preview: Seattle Genetics, ZymoGenetics, Trubion & Other Seattle Biotechs Offer Peeks at Cancer Drug Results
|
Luke Timmerman |
05/15/09 |
Seattle
|
|
Targeted Genetics Faces Extinction, Cell Therapeutics Unloads Debt, Dendreon Raises $221M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/14/09 |
Seattle
|
|
Zymo Melanoma Drug Shrinks Tumors
|
Luke Timmerman |
05/13/09 |
Seattle
|
|
Dendreon’s Hiring Binge, Calistoga’s Venture Round, ZymoGenetics Unloads Drugs, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/07/09 |
Seattle
|
|
ZymoGenetics Drug Sales Still Slumping After Full Year on Market
|
Luke Timmerman |
05/05/09 |
Seattle
|
|
Page 1 of
4 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
